Reports for APOTEX INC
Formerly known as AA PHARMA INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
26 (7%)
Discontinued:
343 (93%)
Reversed:
0 (0%)
369
145 (4%)
73 (30%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-02-09 | 2024-03-08 | 219141 |
| APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131151 |
| APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-07-18 | 2024-08-23 | 233321 |
| APO-DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2020-12-11 | 2021-01-20 | 130040 |
| APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108927 |
| APO-DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2020-03-18 | 2020-03-31 | 108930 |
| APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131148 |
| APO-DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2025-02-13 | 2025-02-21 | 250319 |
| APO-DESMOPRESSIN | 0.1MG | TABLET | Resolved | 2017-07-24 | 2017-12-20 | 16680 |
| APO-DESMOPRESSIN | 0.2MG | TABLET | Resolved | 2024-09-20 | 2024-11-01 | 238230 |
| APO-DESMOPRESSIN | 0.2MG | TABLET | Resolved | 2017-07-24 | 2018-08-15 | 16683 |
| APO-DESMOPRESSIN | 0.1MG | TABLET | Resolved | 2017-05-24 | 2017-06-21 | 11059 |
| APO-DESMOPRESSIN | 0.1MG | TABLET | Resolved | 2017-03-10 | 2017-05-13 | 275 |
| APO-DESMOPRESSIN | 0.2MG | TABLET | Resolved | 2017-03-10 | 2017-06-21 | 278 |
| APO-DESMOPRESSIN | 0.2MG | TABLET | Resolved | 2024-12-05 | 2025-01-31 | 244883 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-02-21 | 2018-03-08 | 40336 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-03 | 2019-01-17 | 71118 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-09-17 | 2020-10-08 | 124344 |
| APO-DESVENLAFAXINE | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-01-14 | 2022-02-18 | 152761 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156987 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |